SPHINGOSINE 1-PHOSPHATE RECEPTOR 1

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 01:11:56 GMT 2025` Edited by `admin` on `Wed Apr 02 01:11:56 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	G72T8FL60W
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SPHINGOSINE 1-PHOSPHATE RECEPTOR 1

Common Name

English

CD363

Preferred Name

English

S1P1

Common Name

English

EDG1

Common Name

English

S1PR1

Common Name

English

SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-1

Common Name

English

S1P RECEPTOR EDG-1

Common Name

English

S1P RECEPTOR 1

Common Name

English

ENDOTHELIAL DIFFERENTIATION G-PROTEIN COUPLED RECEPTOR 1

Common Name

English

CHEDG1

Common Name

English

Code System Code Type Description

UNIPROT

P21453

Created by admin on Wed Apr 02 01:11:56 GMT 2025 , Edited by admin on Wed Apr 02 01:11:56 GMT 2025

PRIMARY

WIKIPEDIA

S1PR1

Created by admin on Wed Apr 02 01:11:56 GMT 2025 , Edited by admin on Wed Apr 02 01:11:56 GMT 2025

PRIMARY

FDA UNII

G72T8FL60W

Created by admin on Wed Apr 02 01:11:56 GMT 2025 , Edited by admin on Wed Apr 02 01:11:56 GMT 2025

PRIMARY

From	To
1_183	1_190
1_281	1_286

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_29
N	1_35

Related Record Type Details


					EK8WS2OJX0

RP-101075

AGONIST -> TARGET

Interaction Type:

SELECTIVE


					0GYJ8CJ1DE

VIBOZILIMOD

AGONIST -> TARGET

Interaction Type:

IN-VITRO, IN-VIVO

Amount:


					6WH8495MMH

ETRASIMOD

AGONIST -> TARGET

Qualification:

EC50

Amount:


					92YDM6122J

FINGOLIMOD PHOSPHATE ESTER, (S)-

AGONIST -> TARGET

Comments:

vivo phosphorylation of FTY720 (1) in rats and humans resulted exclusively in the biologically active (S)-configured enantiomer

Interaction Type:

AGONIST


					RR6P8L282I

Siponimod

AGONIST -> TARGET

Comments:

Siponimod promotes internalization and degradation of S1P1 receptors, thereby acting as a functional antagonist on S1P1. Blocks the capacity of lymphocytes to egress from lymph nodes, reducing the number of lymphocytes in peripheral blood.

Qualification:

EC50

Amount:


					BZ2O8A84A4

CERALIFIMOD

AGONIST -> TARGET

Amount:


					J055N05PGQ

Icanbelimod

AGONIST -> TARGET


					Z633861EIM

ASFOTASE ALFA

AGONIST -> TARGET


					KYS7WW026H

RP-100798

AGONIST -> TARGET

Interaction Type:

SELECTIVE


					Z80293URPV

Ozanimod

AGONIST -> TARGET

Interaction Type:

SELECTIVE

Amount:


					3D22355CDM

CS1P1 C-11

RADIOLIGAND->TARGET

Qualification:

IC50

Amount:


					F2PE1J7HH9

RP-112273

AGONIST -> TARGET

Interaction Type:

SELECTIVE


					QL6WNR6C4D

Amiselimod phosphate

MODULATOR->TARGET

Amount:


					Q1B2AF6KP8

PR-101988

AGONIST -> TARGET

Interaction Type:

SELECTIVE


					Y333RS1786

CENERIMOD

AGONIST -> TARGET

Comments:

Emax = 126%. Chinese Hamster Ovary (CHO) cells, overexpressing human S1P1 receptor (35S)-GTP-S incorporation assays.

Qualification:

EC50

Amount:


					X71GCJ0HLI

Mocravimod

AGONIST -> TARGET


					5G7AKV2MKP

PONESIMOD

AGONIST -> TARGET

Qualification:

EC50

Amount:


					Q2Q3WJK6VL

PR-101442

AGONIST -> TARGET

Interaction Type:

SELECTIVE


					YVE187NJ1U

SPHINGOSINE 1-PHOSPHATE

AGONIST -> TARGET

Qualification:

EC50

Amount:

Structural Modifications

Modification Type	Location Site	Residue Modified	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_9]	LYSINE	N6-ACETYLLYSINE	470AD5VY1X
AMINO ACID SUBSTITUTION	[1_350] [1_352]	SERINE	DEXFOSFOSERINE	VI4F0K069V
AMINO ACID SUBSTITUTION	[1_235]	THREONINE	THREONINE PHOSPHATE	3L4WX7B1EI

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED)	CHEMICAL